InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,792.04
(
0.71%
)
US TECH 100
19,696.00
(
0.63%
)
Dow Jones
42,512.00
(
1.03%
)
Brent Oil
76.57
(
-1.01%
)
Bitcoin
61,059.89
(
-1.73%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

montanus

Send PM Follow Ignore
Followers 13
Posts 1001
Boards Moderated 0
Alias Born 03/12/2009

montanus

Re: None

Monday, 10/01/2012 6:27:33 AM

Monday, October 01, 2012 6:27:33 AM

Post# of 20775
NEW ILNS LONZA Article

http://www.in-pharmatechnologist.com/Processing/Lonza-to-make-antibody-conjugates-for-preclinical-trials?utm_source=copyright&utm_medium=OnSite&utm_campaign


"While it is hard to say how significant the Intellect contract is for Lonza - no financial terms were disclosed - the deal does underline the growing interest top tier contract manufactoring organisations (CMOs) have in ADC development and manufacture."

DOWN WITH THE GRAVITY, UP WITH THE LEVITY

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up